Chronos Archive seal
The Human Record

Mary Shelley

Case HR-NI028 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
August 30, 1797 – February 1, 1851
Synthetic DOB
1974-08-30
Index visit
2026-03-03 at age 51
Synthetic MRN
HR-NI028-SYN

Teaching objective: Evaluate headaches with transient numbness and weakness of one side in a 51-year-old writer: distinguish focal seizures from transient ischemic attack and migraine aura, obtain MRI with gadolinium and an EEG, and give driving and seizure-safety advice at once. Confirm a left convexity meningioma over the motor cortex with vasogenic edema and focal epilepsy; start levetiracetam and monitor mood and irritability; use dexamethasone only for symptomatic edema and briefly; present observation, resection, and stereotactic radiosurgery by shared decision-making (EANO 2021 and NCCN); grade the tumor by the WHO CNS5 criteria after resection, decide on adjuvant treatment by grade and extent of resection, and set the surveillance MRI schedule. Throughout, take a grief history and screen for depression in a woman with many early losses, and protect her ability to write. The teaching note contrasts this with the supposed tumour of the left hemisphere on her death certificate and the hemiplegic migraine hypothesis.

Historical timeline

DateEventClaims
August 30, 1797Born in London.CLM-0001
September 10, 1797Her mother dies eleven days after the birth.CLM-0002
About 1811 to 1812A painful skin disease of one arm at about fourteen.CLM-0010
February 1815Her first child, born prematurely, dies after a few days.CLM-0003
January 1818Frankenstein published.CLM-0004
1818 to June 1819Her daughter Clara and her son William die in Italy.CLM-0005
November 1819Her son Percy Florence is born.CLM-0006
June 1822Near-fatal hemorrhage after a miscarriage.CLM-0007
July 1822Her husband drowns in the Gulf of Spezia.CLM-0008
1823 to 1844Novels, a revised Frankenstein, and travel writing.CLM-0009
1839Recurrent headaches with transient right-sided paralysis and seizures begin.CLM-0012
June 1, 1840Writes in her journal of ill health and extreme depression.CLM-0011
1846 to 1851Lives at 24 Chester Square; her son marries in 1848.CLM-0013
Late 1849 to 1851Worsening illness with impaired speech and loss of power in one side.CLM-0014
February 1, 1851Dies at Chester Square; the certificate records a supposed tumour of the left hemisphere.CLM-0015, CLM-0016, CLM-0017

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Mary Wollstonecraft Godwin was born in London on August 30, 1797, the only child of the writer Mary Wollstonecraft and the philosopher William Godwin. confirmed Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports
Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports
Godwin W. Memoirs of the Author of A Vindication of the Rights of Woman (1798) supports
D Her mother died in London on September 10, 1797, eleven days after the birth, of puerperal fever; her father wrote that the placenta had been retained and had to be removed by hand.
The Bodleian timeline and a reference biography say ten days; the dates in her father's memoir (birth August 30, death September 10) give eleven.
confirmed Godwin W. Memoirs of the Author of A Vindication of the Rights of Woman (1798) supports
Wollstonecraft, Mary 1759–1797. International Encyclopedia of the Social Sciences supports
Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) context
D Her first child, a daughter born prematurely in February 1815, died after a few days.
No health facts about the child are used in this record.
confirmed Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports
D She began the tale that became Frankenstein in Switzerland in the summer of 1816, and Frankenstein; or, The Modern Prometheus was published anonymously in January 1818, when she was 20. confirmed Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports
Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports
D Her daughter Clara died in Italy in 1818, at about one year, and her son William died in Italy in June 1819, at three; she then had no living children.
No health facts about the children are used in this record.
confirmed Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports
Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports
D Her son Percy Florence, born in November 1819, was the only one of her four children to survive childhood. confirmed Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports
Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports
D In June 1822 she nearly died of hemorrhage after a miscarriage about three months into a pregnancy; her husband stopped the bleeding by placing her in ice baths. confirmed Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports
Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports
D In July 1822 her husband, the poet Percy Bysshe Shelley, drowned while sailing in the Gulf of Spezia, leaving her a widow before she was 25, with a son of two; she decided to earn her living by her writing and by publishing his. confirmed Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports
Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports
D She published the novels Valperga (1823) and The Last Man (1826), a revised Frankenstein (1831), and Rambles in Germany and Italy (1844). confirmed Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports
Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports
D At about fourteen she had a very painful skin condition of one entire arm, treated with poultices; at times she could not move the arm and wore it in a sling. It has been interpreted as eczema, psoriasis, or chickenpox.
Her biographer Fiona Sampson as quoted in a 2022 paper; the diagnosis is uncertain.
confirmed Galassi FM, Varotto E, Nerlich A, Bianucci R. Mary Shelley's migraines and fatal stroke: some observations on their primary cause. Acta Biomed 2022;93(1):e2022078. PMID 35315391 supports
D In her journal in June 1840 she wrote that she had been long oppressed by care, disappointment, and ill health, and that lately ill health and extreme depression had marred what little she could do for others.
Her own words; no diagnosis was made in her lifetime.
confirmed Marshall J (Mrs). The Life and Letters of Mary Wollstonecraft Shelley, Volume 2. London: Richard Bentley; 1889 supports
D From 1839 she had recurrent severe headaches of varying severity, site, and duration, with dizziness, pain in the legs, right hand, and right eye, brief episodes of partial paralysis of the right leg and hand, tremors, and convulsive seizures. Her physicians called the illness psychosomatic in 1842, a functional derangement of the nerves or brain in 1845, and neuralgia of the heart in 1846.
Her documented symptoms as summarized in a 2018 Lancet Neurology letter; the diagnoses are those of her time.
confirmed Charlier P, Appenzeller O, Deo S, Perciaccante A, Bianucci R. Hemiplegic migraine and stroke in Mary Shelley. Lancet Neurol 2018;17(4):305. PMID 29553379 supports
Otero Peniche CA. Hemiplegic migraine: the monster. Hektoen International, December 22, 2022 supports
Galassi FM, Varotto E, Nerlich A, Bianucci R. Mary Shelley's migraines and fatal stroke: some observations on their primary cause. Acta Biomed 2022;93(1):e2022078. PMID 35315391 supports
D From 1846 to 1851 she lived at 24 Chester Square, Belgravia, London, and spent time at Field Place in Sussex, the home of her son and his wife after their marriage in 1848.
An 1890 biography says the Chester Square house was given up in 1848 for one in Warwick Square; the 1889 biography and the blue plaque place her at Chester Square until her death.
confirmed Mary Shelley (1797-1851): blue plaque, 24 Chester Square supports
Rossetti LM. Mrs. Shelley (Eminent Women Series). London: W. H. Allen; 1890. Chapter 17 supports
Marshall J (Mrs). The Life and Letters of Mary Wollstonecraft Shelley, Volume 2. London: Richard Bentley; 1889 supports
D Her symptoms worsened from late 1849, with impaired speech and difficulty moving; her nervous ailments increased until she lost power in one side, and she could not be moved from her house in Chester Square.
Later than the synthetic index visit; linked only to a later timeline event.
confirmed Otero Peniche CA. Hemiplegic migraine: the monster. Hektoen International, December 22, 2022 supports
Marshall J (Mrs). The Life and Letters of Mary Wollstonecraft Shelley, Volume 2. London: Richard Bentley; 1889 supports
D She died at Chester Square, London, on February 1, 1851, aged 53. Her death certificate recorded "Disease of the Brain Supposed Tumour in left hemisphere, of long standing." No autopsy was done.
The certificate's wording is documented; the tumour was supposed, not proven (see CLM-0016 and CLM-0017). The 1889 and 1890 biographies give February 21.
confirmed Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports
Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports
Galassi FM, Varotto E, Nerlich A, Bianucci R. Mary Shelley's migraines and fatal stroke: some observations on their primary cause. Acta Biomed 2022;93(1):e2022078. PMID 35315391 supports
Otero Peniche CA. Hemiplegic migraine: the monster. Hektoen International, December 22, 2022 supports
R Her death has long been attributed to a brain tumour: the Bodleian Libraries describe a long illness possibly caused by a brain tumour, and a reference biography says she succumbed to one.
A retrospective interpretation resting on the death certificate's supposed tumour; no tissue or imaging exists.
possible Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) supports
Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia supports
Galassi FM, Varotto E, Nerlich A, Bianucci R. Mary Shelley's migraines and fatal stroke: some observations on their primary cause. Acta Biomed 2022;93(1):e2022078. PMID 35315391 context
R A 2018 Lancet Neurology letter and a 2022 paper argue instead that twelve years of recurrent episodes make a tumour unlikely and that she had hemiplegic migraine with recurrent and finally fatal stroke; the 2022 paper links these to the skin disease of her adolescence.
A competing retrospective interpretation.
disputed Charlier P, Appenzeller O, Deo S, Perciaccante A, Bianucci R. Hemiplegic migraine and stroke in Mary Shelley. Lancet Neurol 2018;17(4):305. PMID 29553379 supports
Galassi FM, Varotto E, Nerlich A, Bianucci R. Mary Shelley's migraines and fatal stroke: some observations on their primary cause. Acta Biomed 2022;93(1):e2022078. PMID 35315391 supports
Otero Peniche CA. Hemiplegic migraine: the monster. Hektoen International, December 22, 2022 supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Headaches, worse in the morning, for about two years, with episodes over six months of tingling and weakness of the right hand and leg lasting a few minutes, one with twitching of the right fingers and one with difficulty finding words; mild right-hand weakness on examination; cause not yet established; urgent MRI and EEG booked resolved confirmed active CLM-0012
S Meningioma of the left frontoparietal convexity over the hand area of the motor cortex, 3.1 x 2.7 x 2.6 cm, with moderate vasogenic edema; resected (Simpson grade I); meningothelial meningioma, CNS WHO grade 1; synthetic modern counterpart of the supposed tumour of the left hemisphere on her death certificate active confirmed both_with_link CLM-0012, CLM-0015, CLM-0016, CLM-0017
S Focal epilepsy due to the left convexity meningioma: focal aware sensory and motor seizures of the right hand and arm, one with speech arrest; EEG with left central sharp waves; on levetiracetam active confirmed both_with_link CLM-0012, CLM-0017
S Acute viral gastroenteritis for two days, with vomiting of one levetiracetam dose, mild dehydration, and no seizure; resolved in four days resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-03-03 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 7 http://loinc.org · 44261-6
S 2026-03-03 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 8 http://loinc.org · 70274-6
S 2026-03-03 Total score [MoCA] 27 http://loinc.org · 72172-0
S 2026-03-03 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-03-03 Potassium [Moles/volume] in Serum or Plasma 4.1 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-03-03 Carbon dioxide, total [Moles/volume] in Serum or Plasma 25 mmol/L
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 2026-03-03 Urea nitrogen [Mass/volume] in Serum or Plasma 13 mg/dL
Reference 6-21 mg/dL
http://loinc.org · 3094-0
S 2026-03-03 Creatinine [Mass/volume] in Serum or Plasma 0.74 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-03-03 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 98 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-03-03 Glucose [Mass/volume] in Serum or Plasma 91 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-03-03 Calcium [Mass/volume] in Serum or Plasma 9.3 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 2026-03-03 Hemoglobin [Mass/volume] in Blood 12.8 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 2026-03-03 Leukocytes [#/volume] in Blood by Automated count 6.1 10*3/uL
Reference 3.4-9.6 10*3/uL
http://loinc.org · 6690-2
S 2026-03-03 Platelets [#/volume] in Blood by Automated count 252 10*3/uL
Reference 157-371 10*3/uL
http://loinc.org · 777-3
S 2026-03-03 Thyrotropin [Units/volume] in Serum or Plasma 1.9 mIU/L
Reference 0.4-4 mIU/L
http://loinc.org · 3016-3
S 2026-03-17 INR in Platelet poor plasma by Coagulation assay 1
Reference 0.8-1.2
http://loinc.org · 6301-6
S 2026-03-17 Hemoglobin [Mass/volume] in Blood 12.7 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 2026-03-17 Platelets [#/volume] in Blood by Automated count 248 10*3/uL
Reference 157-371 10*3/uL
http://loinc.org · 777-3
S 2026-03-17 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 8 http://loinc.org · 44261-6
S 2026-04-28 Glucose [Mass/volume] in Serum or Plasma 96 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-04-28 Sodium [Moles/volume] in Serum or Plasma 138 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-04-28 Hemoglobin [Mass/volume] in Blood 12.1 g/dL
Reference 12-15.5 g/dL
http://loinc.org · 718-7
S 2026-04-28 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 9 http://loinc.org · 44261-6
S 2026-07-07 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 http://loinc.org · 44261-6
S 2026-07-07 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 5 http://loinc.org · 70274-6
S 2026-09-29 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 http://loinc.org · 44261-6
S 2026-09-29 Total score [MoCA] 29 http://loinc.org · 72172-0
S 2026-09-29 Creatinine [Mass/volume] in Serum or Plasma 0.76 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-09-29 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 95 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-08-11 Sodium [Moles/volume] in Serum or Plasma 136 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-08-11 Potassium [Moles/volume] in Serum or Plasma 3.6 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-08-11 Urea nitrogen [Mass/volume] in Serum or Plasma 22 mg/dL (high)
Reference 6-21 mg/dL
http://loinc.org · 3094-0
S 2026-08-11 Creatinine [Mass/volume] in Serum or Plasma 0.91 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-08-11 Glucose [Mass/volume] in Serum or Plasma 88 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-10-20 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 2026-10-20 Total score [AUDIT-C] 1 http://loinc.org · 75626-2

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-03-03Body height160 cm8302-2S
2026-03-03Body weight57.2 kg29463-7S
2026-03-03Body mass index (BMI) [Ratio]22.3 kg/m239156-5S
2026-03-03Systolic blood pressure124 mm[Hg]8480-6S
2026-03-03Diastolic blood pressure78 mm[Hg]8462-4S
2026-03-03Heart rate76 /min8867-4S
2026-03-03Respiratory rate14 /min9279-1S
2026-03-03Body temperature36.7 Cel8310-5S
2026-03-03Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-03-17Body height160 cm8302-2S
2026-03-17Body weight57 kg29463-7S
2026-03-17Body mass index (BMI) [Ratio]22.3 kg/m239156-5S
2026-03-17Systolic blood pressure128 mm[Hg]8480-6S
2026-03-17Diastolic blood pressure80 mm[Hg]8462-4S
2026-03-17Heart rate80 /min8867-4S
2026-03-17Respiratory rate14 /min9279-1S
2026-03-17Body temperature36.6 Cel8310-5S
2026-03-17Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-04-28Body height160 cm8302-2S
2026-04-28Body weight58.1 kg29463-7S
2026-04-28Body mass index (BMI) [Ratio]22.7 kg/m239156-5S
2026-04-28Systolic blood pressure122 mm[Hg]8480-6S
2026-04-28Diastolic blood pressure76 mm[Hg]8462-4S
2026-04-28Heart rate74 /min8867-4S
2026-04-28Respiratory rate14 /min9279-1S
2026-04-28Body temperature36.6 Cel8310-5S
2026-04-28Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-07-07Body height160 cm8302-2S
2026-07-07Body weight57.6 kg29463-7S
2026-07-07Body mass index (BMI) [Ratio]22.5 kg/m239156-5S
2026-07-07Systolic blood pressure118 mm[Hg]8480-6S
2026-07-07Diastolic blood pressure74 mm[Hg]8462-4S
2026-07-07Heart rate70 /min8867-4S
2026-07-07Respiratory rate14 /min9279-1S
2026-07-07Body temperature36.6 Cel8310-5S
2026-07-07Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-09-29Body height160 cm8302-2S
2026-09-29Body weight57.4 kg29463-7S
2026-09-29Body mass index (BMI) [Ratio]22.4 kg/m239156-5S
2026-09-29Systolic blood pressure118 mm[Hg]8480-6S
2026-09-29Diastolic blood pressure74 mm[Hg]8462-4S
2026-09-29Heart rate68 /min8867-4S
2026-09-29Respiratory rate14 /min9279-1S
2026-09-29Body temperature36.5 Cel8310-5S
2026-09-29Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-08-11Body height160 cm8302-2S
2026-08-11Body weight56.3 kg29463-7S
2026-08-11Body mass index (BMI) [Ratio]22 kg/m239156-5S
2026-08-11Systolic blood pressure108 mm[Hg]8480-6S
2026-08-11Diastolic blood pressure70 mm[Hg]8462-4S
2026-08-11Heart rate96 /min8867-4S
2026-08-11Respiratory rate16 /min9279-1S
2026-08-11Body temperature37.6 Cel8310-5S
2026-08-11Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-10-20Body height160 cm8302-2S
2026-10-20Body weight57.5 kg29463-7S
2026-10-20Body mass index (BMI) [Ratio]22.5 kg/m239156-5S
2026-10-20Systolic blood pressure120 mm[Hg]8480-6S
2026-10-20Diastolic blood pressure76 mm[Hg]8462-4S
2026-10-20Heart rate70 /min8867-4S
2026-10-20Respiratory rate14 /min9279-1S
2026-10-20Body temperature36.6 Cel8310-5S
2026-10-20Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
A diagnosis within two weeks, explained in plain words with the images and reports2026-03-17completedMRI and EEG within a week; diagnosis explained at two weeks with the images
No further seizures2027-04-07activeNo seizure since the craniotomy
Full use of the right hand and return to writing every morning2026-09-29completedGrip equal on both sides by three months; writing every morning
Decide on treatment herself after hearing the options, benefits, and harms2026-03-17completedChose resection after observation and radiosurgery were explained
Mood and grief supported: PHQ-9 below 5 and a counselor available2026-09-29completedPHQ-9 4 at six months; completed eight sessions with the neuro-oncology counselor

Interventions

InterventionStatusGuideline
Urgent MRI of the brain with and without gadolinium, with diffusion imaging and MR angiography of the head and neck, within three days; EEG within a week; ECG, blood count, metabolic panel, calcium, and TSH today; headache and episode diarycompletedGL-AAN-SEIZ-2015, GL-NCCN-CNS-2025
Safety now: no driving until the cause is known and her seizures are controlled for the period her state requires; showers rather than baths, no swimming alone, and no work at heights; seizure first aid explained; come at once for a longer episode, weakness that does not recover, or a severe sudden headachecompletedGL-AAN-SEIZ-2015
Neurosurgery consultation if the MRI shows a structural lesion, to explain the options and their risks to her and plan treatment with hercompletedGL-NCCN-CNS-2025
Grief and mood: a grief history, PHQ-9 and GAD-7 at each visit, and the neuro-oncology counselor offered; no assumption that her symptoms are "nerves"completedGL-USPSTF-DEP-2023, GL-CMID-2026
Protect her writing: occupational therapy assessment of hand function if weakness persists, and voice dictation as a backupcompletedGL-NCCN-CNS-2025
Levetiracetam 500 mg twice a day for focal epilepsy due to the meningioma; seizure diary; ask about irritability and low mood at each visit; continue for at least a year after surgery, then decide with her whether to taper after an EEGcompletedGL-AAN-SEIZ-2015, GL-ILAE-EPI-2014, GL-SNO-ASM-2021
Shared decision: resection by craniotomy aiming at Simpson grade I, her choice after observation (not advised for a symptomatic tumor with edema and seizures) and stereotactic radiosurgery (less suitable at 3.1 cm with edema next to the motor cortex) were explained; dexamethasone 4 mg twice a day from three days before surgery, tapered and stopped after it; MRI within 48 hours after surgerycompletedGL-EANO-MEN-2021, GL-NCCN-CNS-2025
After resection of a CNS WHO grade 1 meningioma (Simpson grade I): no radiation; MRI at three months and then yearly for five years, then every two years; no progestin-containing hormone therapy without discussioncompletedGL-EANO-MEN-2021, GL-NCCN-CNS-2025

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Timeline of Mary Wollstonecraft Shelley's Life (Frankenstein exhibition learning resource) Bodleian Libraries, University of Oxford other
SRC-0002 Shelley, Mary (1797–1851). Women in World History: A Biographical Encyclopedia Encyclopedia.com (Gale) biography
SRC-0003 Godwin W. Memoirs of the Author of A Vindication of the Rights of Woman (1798) Project Gutenberg (eBook 16199) primary
SRC-0004 Wollstonecraft, Mary 1759–1797. International Encyclopedia of the Social Sciences Encyclopedia.com (Gale) biography
SRC-0005 Charlier P, Appenzeller O, Deo S, Perciaccante A, Bianucci R. Hemiplegic migraine and stroke in Mary Shelley. Lancet Neurol 2018;17(4):305. PMID 29553379 University of Warwick Research Archive (WRAP) scholarly
SRC-0006 Galassi FM, Varotto E, Nerlich A, Bianucci R. Mary Shelley's migraines and fatal stroke: some observations on their primary cause. Acta Biomed 2022;93(1):e2022078. PMID 35315391 Mattioli 1885 (Università di Palermo IRIS repository) scholarly
SRC-0007 Marshall J (Mrs). The Life and Letters of Mary Wollstonecraft Shelley, Volume 2. London: Richard Bentley; 1889 Project Gutenberg (eBook 37956) biography
SRC-0008 Otero Peniche CA. Hemiplegic migraine: the monster. Hektoen International, December 22, 2022 Hektoen International: A Journal of Medical Humanities other
SRC-0009 Mary Shelley (1797-1851): blue plaque, 24 Chester Square English Heritage government
SRC-0010 Rossetti LM. Mrs. Shelley (Eminent Women Series). London: W. H. Allen; 1890. Chapter 17 Wikisource biography
SRC-0011 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the differential of transient focal episodes, the timing of levetiracetam, the short dexamethasone course, the choice of resection over radiosurgery, the WHO CNS5 grading and the decision against radiation, the surveillance schedule, the driving advice, and the recorded deviations.
provenance reviewnot_startedBodleian Libraries timeline, a Gale reference biography, her father's memoir and a Gale entry for her mother, two peer-reviewed papers (2018 abstract and 2022 full text), a medical-humanities essay, the 1889 and 1890 biographies, and the English Heritage plaque. Her symptoms and the death certificate are D; a brain tumour, and the competing hemiplegic migraine and stroke hypothesis, are R. A meningioma was not found proposed in any fetched source.
safe messaging reviewnot_startedNo behavioral-health diagnosis; mild depressive symptoms and grief are screened and supported, with PHQ-9 never above 9 and item 9 always 0. Her many documented bereavements are summarized without detail, and no statement or decision is attributed to her son or any other relative.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.